Journals in Pharmacology

Advanced Drug Delivery Reviews

ISSN: 0169-409X
5 Year impact factor: 17.6
Impact factor: 15.2

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Artificial Intelligence in the Life Sciences

ISSN: 2667-3185

Providing a scientific forum for practical applications and theoretical advances of Artificial Intelligence (AI) in the life sciences and related disciplines including (but not restricted to):New AI methods for life science researchAdaptation of existing AI concepts for life science applicationsApplication of AI approaches in: Molecular and systems biologyPopulation and disease geneticsBio- and cheminformaticsMedicinal chemistry, chemical biology, and drug discoveryMedical researchPublications are required to contain substantial AI and life science components. Clinical studies reporting routine diagnostic efforts hall outside the scope of AILSCI.Background: Artificial Intelligence originates from computer science and covers a wide range of approaches intended to enhance the ability of machines to make data-driven decisions and accurate predictions of events. In many scientific fields, AI is being increasingly considered and integrated, especially in the context of Big Data. Given their complexity and highly interdisciplinary nature, the life sciences provide ample opportunities for AI to impact R&D efforts in a variety of ways.Key words: Artificial Intelligence; Life Sciences; Drug Discovery; Bio- and Cheminformatics, Machine Learning; Machine Intelligence; Deep Learning; Data Mining; Big Data.

Clinical Therapeutics

ISSN: 0149-2918
5 Year impact factor: 3
Impact factor: 3.2

The International Peer-Reviewed Journal of Drug TherapyClinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolera-bility in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editorialmanager.com/clinther.

Drug Metabolism and Disposition

ISSN: 0090-9556

An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolism enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.

Future Healthcare Journal

ISSN: 2514-6645

Future Healthcare Journal (FHJ) is a peer-reviewed academic journal with a multidisciplinary editorial board stimulating debate about all aspects of future healthcare. Each issue has a theme featuring commissioned articles from national and international experts providing authoritative overviews as well as submitted papers. Themed issues are published online when collated but all accepted articles are available immediately for rapidity of referencing and citation. Articles feature digital health and artificial intelligence, illness prevention, multidisciplinary workforce planning, system re-engineering, population health, lifestyle medicine and therapeutic advances. The emphasis is on providing practical solutions to current healthcare challenges. It has strong involvement of trainees and encourages submissions on QI and audit rarely found in other journals. FHJ tackles contentious issues and aims to provide readers with the tools to facilitate transformational change at an individual and organisational level. Articles should be of interest and understandable to a broad audience of healthcare professionals and leaders who may be involved in making system changes in their own organisation. While the journal is affiliated with the Royal College of Physicians (RCP), it has full editorial independence.From January 1, 2024, Future Healthcare Journal becomes a full gold open access journal freely available for everyone to access and read. All articles submitted after January 1, 2024, are subject to an article publishing charge (APC) after peer review and acceptance. We are pleased to inform you that Future Healthcare Journal waives the APC (Article Publishing Charge) for all submissions received before 31 December 2025, which are accepted for publication after peer review. Learn more about hybrid journals moving to open access.

Heliyon

ISSN: 2405-8440
5 Year impact factor: 3.9
Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Journal of Holistic Integrative Pharmacy

ISSN: 2707-3688

Journal of Holistic Integrative Pharmacy is an open-access journal, officially sponsored by Guangdong Pharmaceutical University and China Institute for Development Strategy of Holistic Integrative Medicine. With the aim of promoting academic exchanges and disciplinary development of pharmaceutical sciences, this journal provides an important platform for the communication of holistic integrative pharmacy and its related disciplines.Spanning all aspects in the integration of various relevant disciplines of pharmaceutical sciences, such as the combination of pharmacy with traditional medicine, pharmacy with modern medicine, pharmacy with modern new technology, basic pharmaceutical research with application and development, pharmacy with humanities, etc. This journal publishes a range of article types, including highlights, reviews, and original research.Editorial Board

Medicine in Drug Discovery

ISSN: 2590-0986

Medicine in Drug Discovery is a peer-reviewed open access journal. The journal publishes original papers related to basic, preclinical and clinical studies covering all aspects of drug discovery and development. Clinical studies with a focus on efficacy and safety, target engagement, biomarkers, PK/PD, side effects etc. are also covered in the journal.Article types accepted include, but are not limited to, original research articles, reviews, case reports, short communications and editorials.The journal is in cooperation with The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.Benefits to authorsWe provide many author benefits, such as APC waivers for accepted manuscripts submitted by 31 December 2020, certificate of publication for your article and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Molecular Pharmacology

ISSN: 0026-895X

Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism

OpenNano

ISSN: 2352-9520

OpenNano is an internationally peer-reviewed and open-access journal publishing high-quality original research articles and reviews focusing on the application of nanoscience and nanotechnology, with an emphasis on conceptual novelty and scientific quality.OpenNano publishes research from basic to translational and clinical settings with the aim to bring together pharmaceutical scientists, chemists, biotechnologists, material scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.The journal publishes topics including:NanoparticlesPolymeric NanoparticlesLiposomes and Solid Lipid NanoparticlesNanovesciclesExosomesNanostructured MaterialsNanocrystals and Quantum DotsNanotubes and Nanoporous MaterialsFunctional NanomaterialsNanosystemsNanodevicesSelf-Assembly

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Pharmacology